NOG Antikörper (AA 28-130)
Kurzübersicht für NOG Antikörper (AA 28-130) (ABIN873145)
Target
Alle NOG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 28-130
-
Verwendungszweck
- Noggin Polyclonal Antibody
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Noggin
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Expression characteristics of BMP2, BMPR-IA and Noggin in different stages of hair follicle in yak skin." in: General and comparative endocrinology, Vol. 260, pp. 18-24, (2017) (PubMed).
-
-
- NOG (Noggin (NOG))
-
Andere Bezeichnung
- Noggin
-
Hintergrund
-
Synonyms: NOG, NOGG_HUMAN, Noggin, SYM 1, SYM1, Symphalangism 1 proximal, Synostoses multiple syndrome 1, SYNS 1, SYNS1.
Background: Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Essential for cartilage morphogenesis and joint formation. Inhibits chondrocyte differentiation through its interaction with GDF5 (PubMed:21976273).
-
Gen-ID
- 9241
-
UniProt
- Q13253
-
Pathways
- Stem Cell Maintenance, Tube Formation
Target
-